Avita is a single product company... Show more
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
RCEL moved above its 50-day moving average on October 01, 2025 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for RCEL crossed bullishly above the 50-day moving average on September 22, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RCEL advanced for three days, in of 281 cases, the price rose further within the following month. The odds of a continued upward trend are .
The 10-day RSI Indicator for RCEL moved out of overbought territory on September 17, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on September 29, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RCEL as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for RCEL turned negative on September 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCEL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
RCEL broke above its upper Bollinger Band on September 15, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RCEL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (54.054) is normal, around the industry mean (60.880). P/E Ratio (0.000) is within average values for comparable stocks, (37.305). RCEL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.679). RCEL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (1.839) is also within normal values, averaging (80.090).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
a company, which engages in the development and distribution of regenerative and respiratory medicine and treatments
Industry MedicalNursingServices
A.I.dvisor indicates that over the last year, RCEL has been loosely correlated with MRCHF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if RCEL jumps, then MRCHF could also see price increases.
Ticker / NAME | Correlation To RCEL | 1D Price Change % | ||
---|---|---|---|---|
RCEL | 100% | +4.19% | ||
MRCHF - RCEL | 38% Loosely correlated | N/A | ||
MBOT - RCEL | 33% Poorly correlated | +0.32% | ||
TRUMY - RCEL | 31% Poorly correlated | -2.24% | ||
NTRA - RCEL | 30% Poorly correlated | -0.87% | ||
CTKB - RCEL | 30% Poorly correlated | +1.11% | ||
More |
Ticker / NAME | Correlation To RCEL | 1D Price Change % |
---|---|---|
RCEL | 100% | +4.19% |
Medical/Nursing Services industry (224 stocks) | 23% Poorly correlated | +0.43% |
Health Services industry (435 stocks) | 18% Poorly correlated | +0.30% |